Paul W. Hoelscher Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Paul W. Hoelscher is EVP, CFO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 1,049 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2021, when has been sold 205,638 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.05K

0% 3M change

0% 12M change

Total Value Held $0

Paul W. Hoelscher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2021	BUY Grant, award, or other acquisition	-	205,638 Added 40.28%	304,879 Ordinary Shares
Jan 05 2021	BUY Exercise of conversion of derivative security	-	98,192 Added 49.73%	99,241 Ordinary Shares
Feb 26 2020	SELL Bona fide gift	-	11,452 Reduced 100.0%	0 Ordinary Shares
Feb 19 2020	SELL Payment of exercise price or tax liability	$239,763 $36.06 p/Share	6,649 Reduced 36.82%	11,407 Ordinary Shares
Feb 19 2020	BUY Grant, award, or other acquisition	-	15,007 Added 45.39%	18,056 Ordinary Shares
Feb 14 2020	SELL Bona fide gift	-	226,043 Reduced 98.67%	3,049 Ordinary Shares
Jan 21 2020	SELL Payment of exercise price or tax liability	$94,133 $38.25 p/Share	2,461 Reduced 1.06%	229,137 Ordinary Shares
Jan 21 2020	BUY Grant, award, or other acquisition	-	5,555 Added 2.34%	231,598 Ordinary Shares
Jan 05 2020	SELL Payment of exercise price or tax liability	$2,502,488 $36.1 p/Share	69,321 Reduced 23.47%	226,043 Ordinary Shares
Jan 05 2020	BUY Grant, award, or other acquisition	-	72,376 Added 19.68%	295,364 Ordinary Shares
Jan 05 2020	BUY Exercise of conversion of derivative security	-	83,678 Added 27.29%	222,988 Ordinary Shares
Oct 15 2019	SELL Open market or private sale	$560,200 $28.01 p/Share	20,000 Reduced 12.55%	139,310 Ordinary Shares
Aug 30 2019	SELL Open market or private sale	$38,052 $28.0 p/Share	1,359 Reduced 0.85%	159,310 Ordinary Shares
Aug 22 2019	BUY Exercise of conversion of derivative security	$563,423 $19.05 p/Share	29,576 Added 15.55%	160,669 Ordinary Shares
Aug 21 2019	SELL Open market or private sale	$1,985,993 $28.01 p/Share	70,903 Reduced 35.1%	131,093 Ordinary Shares
Mar 23 2019	SELL Payment of exercise price or tax liability	$368,594 $26.84 p/Share	13,733 Reduced 6.44%	199,626 Ordinary Shares
Mar 23 2019	BUY Exercise of conversion of derivative security	-	31,000 Added 12.69%	213,359 Ordinary Shares
Feb 20 2019	SELL Payment of exercise price or tax liability	$690,659 $21.54 p/Share	32,064 Reduced 14.95%	182,359 Ordinary Shares
Feb 20 2019	BUY Grant, award, or other acquisition	-	72,375 Added 25.24%	214,423 Ordinary Shares
Jan 05 2019	SELL Payment of exercise price or tax liability	$599,853 $20.39 p/Share	29,419 Reduced 17.16%	142,048 Ordinary Shares
Jan 05 2019	BUY Exercise of conversion of derivative security	-	65,695 Added 27.7%	171,467 Ordinary Shares
Jun 23 2018	SELL Payment of exercise price or tax liability	$156,556 $17.67 p/Share	8,860 Reduced 7.73%	105,772 Ordinary Shares
Jun 23 2018	BUY Exercise of conversion of derivative security	-	20,000 Added 14.86%	114,632 Ordinary Shares
Mar 23 2018	SELL Payment of exercise price or tax liability	$190,339 $13.86 p/Share	13,733 Reduced 12.96%	92,262 Ordinary Shares
Mar 23 2018	BUY Exercise of conversion of derivative security	-	31,000 Added 22.63%	105,995 Ordinary Shares

Also insider at

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

Director

SGMT

Sagimet Biosciences Inc.

Director

PWH

Paul W. Hoelscher

EVP, CFO

Dublin, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Value

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP

Account